Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
United States

100%
Zoom level changed to 1
Global PrEP Tracker
Last Updated: 5 March 2025

Drug Registration Status

Approved
Not
Approved
Under
Review
Data not
available
Gilead's Truvada (TDF/xTC*) Registration
Approved 2012 2012
Generic versions of TDF/xTC* for prevention
Approved N/A N/A
ViiV's Apretude (CAB for PrEP) Registration
Approved 2021 2021
IPM's Dapivirine Vaginal Ring Registration
Not Approved
Oral F/TAF (Descovy) Registration
Approved 2019 2019
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

7 Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

8 Planned/Ongoing Projects

Policy Frameworks

USA National PrEP Guidelines, 2021

USA National HIV/AIDS Strategy, 2022-25

USA HIV National Strategic Plan A Roadmap to End the Epidemic, 2021-25

Est. Cumulative
Initiations:

Total PrEP: 525,825

Oral PrEP: 511,769

Dapivirine Vaginal Ring: N/A

Injectable PrEP: 14,056

Where To Access PrEP in United States:

PrEP Locator

Please PrEP Me

Descovy

HIV Care Now

HIV.gov

Apretude

AIDSVu

Featured Resources

External Link

AIDSVu

AIDSVu is an interactive online mapping tool that visualizes the impact of the HIV epidemic on communities across the United States to increase disease awareness and promote data-driven public health decision-making. This includes information on PrEP use and need from national to city level.
Document

NIAID HIV Language Guide, 2024

This language guide outlines the current development in language and communication associated with the HIV field. It serves to aid stakeholders in effectively communicating about HIV and support information flow about HIV by suggesting empowering language in place of stigmatizing language.
View All Resources